Mechanisms linking the hemostatic protease thrombin to arthritic disease
止血蛋白酶凝血酶与关节炎疾病的联系机制
基本信息
- 批准号:8522260
- 负责人:
- 金额:$ 24.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-10 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAffectAnti-Inflammatory AgentsAnti-inflammatoryAnticoagulantsArthritisAutoimmune DiseasesAutomobile DrivingCartilageCatalytic DomainChronicCoagulantsCollagen ArthritisComplementDepositionDevelopmentDiseaseEngineeringEnzymesEventExperimental ArthritisFactor XIIIFibrinFibrinogenFibrinolysisGene TargetingGenerationsGenesGeneticGoalsHealthHemostatic AgentsHumanHyperplasiaImmune systemInflammationInflammatoryInjuryJointsKnock-in MouseLinkMediatingMolecularMusMutationOnset of illnessPathogenesisPeptide HydrolasesPharmacia brand of estropipatePhysiologicalProcessProtease DomainProtein CProtein C InhibitorProthrombinResearchRheumatoid ArthritisRoleSerine ProteaseSeveritiesSeverity of illnessSiteSpecificitySubstrate SpecificitySurfaceSystemTestingThrombinTissuesTransglutaminasesVariantWild Type MouseWorkarthropathiesbonecrosslinkcytokinejoint functionloss of functionmonomermutantnovelnovel therapeuticsosteopontinpolymerization
项目摘要
DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is a common and extremely debilitating inflammatory disease that results in erosion and degradation of joint tissue and ultimately loss of function. Activation of the hemostatic system and the subsequent conversion of prothrombin to the active serine protease thrombin is a prominent feature of RA. Robust fibrin deposition within affected joints is one pathological consequence of exuberant thrombin activity, and fibrin(ogen) has recently been shown to drive inflammatory events associated with arthritis pathogenesis. Importantly, fibrinogen appears to be just one of many downstream effectors by which thrombin regulates events central to arthritis pathogenesis. The aims of this proposal will focus on the following specific hypotheses: (1) thrombin promotes the local inflammation, synovial hyperplasia, pannus formation, and cartilage/bone destruction associated with arthritic disease, (2) thrombin-induced fibrin polymerization and activation of the fXIII transglutaminase which cross-links fibrin are two mechanisms by which thrombin exacerbates inflammatory joint disease, and (3) "re-engineering" thrombin substrate specificity to promote anticoagulant/anti-inflammatory activity over procoagulant activity will convert the enzyme from a pro-arthritic to an anti-arthritic factor. These hypotheses will be tested using recently established gene-targeted mouse lines and the well-established experimental setting of collagen-induced arthritis. The specific effect(s) of a genetically-imposed reduction in circulating prothrombin in conjunction with fibrinogen-deficient mice will define the role of the thrombin-fibrinogen axis on arthritis pathogenesis (Aim 1). By employing mice that either express a form of fibrinogen insensitive to thrombin protease activity or that carry a genetic ablation of the transglutaminase fXIIIA catalytic subunit gene, the mechanistic role of thrombin-mediated fibrin polymerization and cross-linking on arthritis progression will be specifically evaluated (Aim 2). Finally, mice carrying a site- directed mutation in the prothrombin gene that results in a shift in substrate specificity away from procoagulant to anticoagulant/anti-inflammatory targets will be used to investigate the concept that thrombin can be redirected to serve as an anti-arthritic enzyme (Aim 3). The proposed studies will fill significant gaps in our current understanding of arthritis pathogenesis by defining mechanisms of cross-talk between the hemostatic and inflammatory systems that drive arthritis pathogenesis and may highlight novel therapeutic opportunities for the treatment of arthritis. PUBLIC HEALTH RELEVANCE: Activation of the hemostatic system, including generation of the central hemostatic serine protease thrombin, is a prominent feature of both human rheumatoid arthritis and experimental inflammatory arthritis. The long-term goal of these studies is to determine the role of thrombin in the pathogenesis of inflammatory joint disease. The proposed work will fill significant gaps in our understanding of the interplay between the thrombin- fibrinogen axis and arthritic disease, and may provide the proof-of-principle for the use of novel "customized" thrombin variants with selected substrate specificity to treat arthritis.
描述(由申请人提供):类风湿性关节炎(RA)是一种常见且极度衰弱的炎症性疾病,导致关节组织的侵蚀和降解,最终导致功能丧失。止血系统的激活和凝血酶原随后转化为活性丝氨酸蛋白酶凝血酶是RA的一个突出特征。受影响关节内的纤维蛋白沉积是凝血酶活性旺盛的一个病理结果,纤维蛋白(原)最近被证明可以驱动与关节炎发病相关的炎症事件。重要的是,纤维蛋白原似乎只是凝血酶调节关节炎发病中心事件的众多下游效应物之一。本建议的目的将集中于以下具体假设:(1)凝血酶促进与关节炎疾病相关的局部炎症、滑膜增生、肠膜形成和软骨/骨破坏;(2)凝血酶诱导的纤维蛋白聚合和与纤维蛋白交联的fXIII转谷氨酰胺酶的激活是凝血酶加重炎性关节疾病的两种机制。(3)“重新设计”凝血酶底物特异性,以促进抗凝/抗炎活性超过促凝活性,将酶从促关节炎因子转化为抗关节炎因子。这些假设将使用最近建立的基因靶向小鼠系和已建立的胶原诱导关节炎的实验设置进行测试。基因强加的循环凝血酶原减少与纤维蛋白原缺陷小鼠的特异性作用将确定凝血酶-纤维蛋白原轴在关节炎发病中的作用(目的1)。通过使用表达对凝血酶蛋白酶活性不敏感的纤维蛋白原形式或携带转谷氨酰胺酶fXIIIA催化亚基基因基因消融的小鼠,将特别评估凝血酶介导的纤维蛋白聚合和交联在关节炎进展中的机制作用(目的2)。最后,携带凝血酶原基因位点定向突变的小鼠将导致底物特异性从促凝剂转移到抗凝/抗炎靶点,以研究凝血酶可以被重定向作为抗关节炎酶的概念(目的3)。拟议的研究将填补我们目前对关节炎发病机制的理解的重大空白,通过定义驱动关节炎发病机制的止血和炎症系统之间的相互作用机制,并可能为关节炎的治疗提供新的治疗机会。公共卫生相关性:止血系统的激活,包括中央止血丝氨酸蛋白酶凝血酶的产生,是人类类风湿关节炎和实验性炎症性关节炎的一个突出特征。这些研究的长期目标是确定凝血酶在炎症性关节疾病发病机制中的作用。提出的工作将填补我们对凝血酶-纤维蛋白原轴与关节炎疾病之间相互作用的理解中的重大空白,并可能为使用具有选定底物特异性的新型“定制”凝血酶变体治疗关节炎提供原理证明。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW J FLICK其他文献
MATTHEW J FLICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW J FLICK', 18)}}的其他基金
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
通过靶向肿瘤微环境中的凝血来重编程 PDAC 基质
- 批准号:
10681313 - 财政年份:2022
- 资助金额:
$ 24.87万 - 项目类别:
Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment
通过靶向肿瘤微环境中的凝血来重编程 PDAC 基质
- 批准号:
10517972 - 财政年份:2022
- 资助金额:
$ 24.87万 - 项目类别:
2022 Plasminogen Activation and Extracellular Proteolysis Gordon Research Conference and Seminar
2022年纤溶酶原激活和细胞外蛋白水解戈登研究会议暨研讨会
- 批准号:
10386008 - 财政年份:2021
- 资助金额:
$ 24.87万 - 项目类别:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
纤溶酶原/纤维蛋白原轴与 COVID-19 发病机制的联系机制
- 批准号:
10471424 - 财政年份:2021
- 资助金额:
$ 24.87万 - 项目类别:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
纤溶酶原/纤维蛋白原轴与 COVID-19 发病机制的联系机制
- 批准号:
10676149 - 财政年份:2021
- 资助金额:
$ 24.87万 - 项目类别:
Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19
纤溶酶原/纤维蛋白原轴与 COVID-19 发病机制的联系机制
- 批准号:
10316657 - 财政年份:2021
- 资助金额:
$ 24.87万 - 项目类别:
Fibrin(ogen) control of metabolic inflammation and obesity
纤维蛋白(原)控制代谢炎症和肥胖
- 批准号:
10311076 - 财政年份:2018
- 资助金额:
$ 24.87万 - 项目类别:
Fibrin(ogen) control of metabolic inflammation and obesity
纤维蛋白(原)控制代谢炎症和肥胖
- 批准号:
10065070 - 财政年份:2018
- 资助金额:
$ 24.87万 - 项目类别:
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
靶向纤溶酶原激活系统以限制胰腺癌进展和相关血栓形成
- 批准号:
10458582 - 财政年份:2018
- 资助金额:
$ 24.87万 - 项目类别:
Fibrin(ogen) control of metabolic inflammation and obesity
纤维蛋白(原)控制代谢炎症和肥胖
- 批准号:
10083730 - 财政年份:2018
- 资助金额:
$ 24.87万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 24.87万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Studentship